Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-11-03 00:00:00 ET · period of report 2022-11-01 · accession 0000899243-22-034953 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-03 | 2022-11-01 | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $2.77 | -196.3K | 22.78M | -0.9% | -$543.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-01 | S | D | 196,308 | $2.77 | 22,780,065 | D | — | — |